PMC:7094172 / 4135-4332 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T68","span":{"begin":6,"end":22},"obj":"CHEBI:41237;CHEBI:41237"},{"id":"T67","span":{"begin":81,"end":90},"obj":"PG_4"},{"id":"T66","span":{"begin":194,"end":195},"obj":"PG_4"}],"text":"nly 5-benzyloxygramine (P3) had both antiviral and stabilizing activities on the N protein. Small-angle X-ray scattering (SAXS) and cell-based assays showed that P3 induces abnormal full-length N p"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T27","span":{"begin":83,"end":90},"obj":"Body_part"},{"id":"T28","span":{"begin":132,"end":136},"obj":"Body_part"}],"attributes":[{"id":"A27","pred":"fma_id","subj":"T27","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A28","pred":"fma_id","subj":"T28","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"nly 5-benzyloxygramine (P3) had both antiviral and stabilizing activities on the N protein. Small-angle X-ray scattering (SAXS) and cell-based assays showed that P3 induces abnormal full-length N p"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T26","span":{"begin":63,"end":73},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T27","span":{"begin":132,"end":136},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"nly 5-benzyloxygramine (P3) had both antiviral and stabilizing activities on the N protein. Small-angle X-ray scattering (SAXS) and cell-based assays showed that P3 induces abnormal full-length N p"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T48","span":{"begin":37,"end":46},"obj":"Chemical"},{"id":"T49","span":{"begin":83,"end":90},"obj":"Chemical"}],"attributes":[{"id":"A48","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A49","pred":"chebi_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"nly 5-benzyloxygramine (P3) had both antiviral and stabilizing activities on the N protein. Small-angle X-ray scattering (SAXS) and cell-based assays showed that P3 induces abnormal full-length N p"}

{"project":"LitCovid-PubTator","denotations":[{"id":"80","span":{"begin":4,"end":22},"obj":"Chemical"},{"id":"81","span":{"begin":24,"end":26},"obj":"Chemical"},{"id":"82","span":{"begin":162,"end":164},"obj":"Chemical"}],"attributes":[{"id":"A80","pred":"tao:has_database_id","subj":"80","obj":"MESH:C006736"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nly 5-benzyloxygramine (P3) had both antiviral and stabilizing activities on the N protein. Small-angle X-ray scattering (SAXS) and cell-based assays showed that P3 induces abnormal full-length N p"}